Target intelligence / Profile preview

MicroRNA 582 (MIR582)

Target
MIR582
Molecular classification
MicroRNA, Non-coding RNA, Epigenetic regulator
01

Overview

MicroRNA 582 (MIR582) is a human non-coding RNA gene that produces two mature microRNAs: hsa-miR-582-5p and hsa-miR-582-3p[1][2]. These small regulatory RNAs play post-transcriptional roles in gene silencing, impacting mRNA stability and translation[3]. MIR582 is implicated in multiple biological functions including regulation of cell proliferation, apoptosis, and maintenance of stemness in both cancer stem cells and neural stem cells[1][3]. In cancer, miR-582-5p and miR-582-3p have been shown to both suppress and promote tumor progression depending on the context, for example, by targeting oncogenic pathways (including NOTCH1 and Hippo-YAP/TAZ) or enhancing epithelial-mesenchymal transition (EMT)[1][4][5][6][7]. The molecule serves as a biomarker for tumorigenicity and may represent a novel therapeutic target, though no approved drugs directly target MIR582 to date. Safety concerns involve the broad regulatory functions of microRNAs, raising issues for off-target effects and the impact on normal stem cell function[3].

Other names
hsa-mir-582MIRN582hsa-miR-582-3phsa-miR-582-5p
02

Mechanism of action

Regulates gene expression by binding to target mRNAs, leading to mRNA degradation or repression of translation\n- Suppression of oncogenic pathways (e.g., Hippo-YAP/TAZ, NOTCH1)

03

Biological functions

Post-transcriptional gene regulationCell proliferationCell cycle regulationApoptosisMaintenance of stemness (including cancer stem cells and neural stem cells)Epithelial-mesenchymal transition (EMT)Differentiation
04

Disease associations

Cancer (notably non-small-cell lung cancer, acute myeloid leukemia, pituitary adenoma, other solid tumors)Neurodevelopmental/neurological processesPotential roles in inflammation and other diseases via stem cell regulation
05

Safety considerations

Potential off-target effects due to pleiotropic regulation of multiple genesRisk of affecting normal stem cell maintenance and differentiation when therapeutically targeting miR-582
06

Biomarkers

Expression level of miR-582-5p and miR-582-3p as biomarkers for tumor stemness, prognosis, or progression in certain cancersE-cadherin, Vimentin (target protein expression changes associated with miR-582 activity in cancer)

Beyond the preview

Go deeper on MicroRNA 582 (MIR582).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 582 (MIR582).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call